Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Fatigue in multiple sclerosis - A brief review.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
Characterization of human platelet binding of recombinant T cell receptor ligand.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
MS and NMO: Partners No More.
Substance Name: Naltrexone
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Severe haematological complications during treatment with natalizumab.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.
Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Chronic inflammatory demyelinating polyneuropathy following malignant melanoma.
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
Pages
« first
‹ previous
…
118
119
120
121
122
123
124
125
126
…
next ›
last »